The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Emerging roles of TEAD transcription factors and its coactivators in cancers
Open accessAbstract
TEAD proteins are transcription factors that are crucial for development, but also play a role in cancers. Several developmentally and pathologically important genes are upregulated by TEADs. TEADs have a TEA domain that enables them to bind specific DNA elements and a transactivation domain that enables them to interact with coactivators. TEADs on their own are unable to activate transcription and they require the help of coactivators. Several TEAD-interacting coactivators are known and they can be classified into three groups: (1) YAP and its paralog TAZ; (2) Vgll proteins; and (3) p160s. Accordingly, these coactivators also play a role in development and cancers. Recent studies have shown that TEADs and their coactivators aid in the progression of various cancers, including the difficult to treat glioblastoma, liver and ovarian cancers. They facilitate cancer progression through expression of proliferation promoting genes such as c-myc, survivin, Axl, CTGF and Cyr61. There is also a good correlation between high TEAD or its coactivator expression and poor prognosis in various cancers. Given the fact that TEADs and their coactivators need to work together for a functional outcome, disrupting the interaction between them appears to be a viable option for cancer therapy. Structures of TEAD-coactivator complexes have been elucidated and will facilitate drug design and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Ellenberger, T. E., Brandl, C. J., Struhl, K., & Harrison, S. C. (1992) · Cell · doi:10.1016/s0092-8674(05)80070-4 · Cited by 972
Structure and specificity of nuclear receptor–coactivator interactions
Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., & Yamamoto, K. R. (1998) · Genes & Development · doi:10.1101/gad.12.21.3343 · Cited by 924
X chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., Chinnaiyan, A., Israel, M. A., Goldstein, L. S. B., Abujarour, R., et al. (2010) · Genes & Development · doi:10.1101/gad.1903310 · Cited by 745
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
Yagi, R., Chen, L.-F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 558
Errani, C., Zhang, L., Sung, Y. S., Hajdu, M., Singer, S., Maki, R. G., Healey, J. H., & Antonescu, C. R. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20886 · Cited by 553
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S., et al. (2013) · Nature · doi:10.1038/nature11693 · Cited by 543
Yagi, R., Kohn, M. J., Karavanova, I., Kaneko, K. J., Vullhorst, D., DePamphilis, M. L., & Buonanno, A. (2007) · Development · doi:10.1242/dev.010223 · Cited by 531
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
Voegel, J. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.507 · Cited by 515
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Hong, W., & Guan, K.-L. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.05.004 · Cited by 493
Self-citationA Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., & Hong, W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2696 · Cited by 478
Self-citationMorin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W., & Milgram, S. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.77-87.2006 · Cited by 429
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
Strano, S., Munarriz, E., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G., & Blandino, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010484200 · Cited by 422
Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1
Xiao, J. H., Davidson, I., Matthes, H., Garnier, J.-M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90088-g · Cited by 419
Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416
Structural insights into the YAP and TEAD complex
Li, Z., Zhao, B., Wang, P., Chen, F., Dong, Z., Yang, H., Guan, K.-L., & Xu, Y. (2010) · Genes & Development · doi:10.1101/gad.1865810 · Cited by 401
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Tanas, M. R., Sboner, A., Oliveira, A. M., Erickson-Johnson, M. R., Hespelt, J., Hanwright, P. J., Flanagan, J., Luo, Y., Fenwick, K., Natrajan, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002409 · Cited by 401
Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009) · Genes & Development · doi:10.1101/gad.1824509 · Cited by 377
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Bhat, K. P. L., Salazar, K. L., Balasubramaniyan, V., Wani, K., Heathcock, L., Hollingsworth, F., James, J. D., Gumin, J., Diefes, K. L., Kim, S. H., et al. (2011) · Genes & Development · doi:10.1101/gad.176800.111 · Cited by 377
Wang, Y., Dong, Q., Zhang, Q., Li, Z., Wang, E., & Qiu, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01511.x · Cited by 343
Bladder Cancer Outcome and Subtype Classification by Gene Expression
Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., DeVries, S., Koppie, T., Pejavar, S., Carroll, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2409 · Cited by 337
Chen, Z., Friedrich, G. A., & Soriano, P. (1994) · Genes & Development · doi:10.1101/gad.8.19.2293 · Cited by 331
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1
Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W., & Hunziker, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605266104 · Cited by 297
Self-citationMakita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00201.2007 · Cited by 293
Neto-Silva, R. M., de Beco, S., & Johnston, L. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.009 · Cited by 287
Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.197582.112 · Cited by 282
Snijders, A. M., Schmidt, B. L., Fridlyand, J., Dekker, N., Pinkel, D., Jordan, R. C. K., & Albertson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208601 · Cited by 280
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Chen, L., Chan, S. W., Zhang, X., Walsh, M., Lim, C. J., Hong, W., & Song, H. (2010) · Genes & Development · doi:10.1101/gad.1865310 · Cited by 249
Self-citationAXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
Xu, M. Z., Chan, S. W., Liu, A. M., Wong, K. F., Fan, S. T., Chen, J., Poon, R. T., Zender, L., Lowe, S. W., Hong, W., et al. (2011) · Oncogene · doi:10.1038/onc.2010.504 · Cited by 228
Self-citationYAP is a candidate oncogene for esophageal squamous cell carcinoma
Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K.-I., Haruki, S., Sudol, M., Shimada, Y., Tsuda, H., Kawano, T., & Inazawa, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq254 · Cited by 227
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Mann, K. M., Ward, J. M., Yew, C. C. K., Kovochich, A., Dawson, D. W., Black, M. A., Brett, B. T., Sheetz, T. E., Dupuy, A. J., Initiative, A. P. C. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202490109 · Cited by 213
Modena, P., Lualdi, E., Facchinetti, F., Veltman, J., Reid, J. F., Minardi, S., Janssen, I., Giangaspero, F., Forni, M., Finocchiaro, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3701 · Cited by 207
Ishiji, T., Lace, M. J., Parkkinen, S., Anderson, R. D., Haugen, T. H., Cripe, T. P., Xiao, J. H., Davidson, I., Chambon, P., & Turek, L. P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05286.x · Cited by 191
TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex
Tian, Y., Kolb, R., Hong, J.-H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M. B., Zhou, J., & Benjamin, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00254-07 · Cited by 187
Sawada, A., Kiyonari, H., Ukita, K., Nishioka, N., Imuta, Y., & Sasaki, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01759-07 · Cited by 176
Maeda, T., Chapman, D. L., & Stewart, A. F. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206858200 · Cited by 174
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Pobbati, A. V., Chan, S. W., Lee, I., Song, H., & Hong, W. (2012) · Structure · doi:10.1016/j.str.2012.04.004 · Cited by 169
Self-citationStructural and functional analysis of the YAP-binding domain of human TEAD2
Tian, W., Yu, J., Tomchick, D. R., Pan, D., & Luo, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000293107 · Cited by 169
The Evolutionary History of YAP and the Hippo/YAP Pathway
Hilman, D., & Gat, U. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr065 · Cited by 166
TAZ is a novel oncogene in non-small cell lung cancer
Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.-S., & Yang, X. (2011) · Oncogene · doi:10.1038/onc.2010.606 · Cited by 162
Nord, K. H., Sciot, R., Staaf, J., Heidenblad, M., Rydholm, A., Bauer, H. C. F., Åström, K., Domanski, H. A., Meis, J. M., Kindblom, L., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2513 · Cited by 157
Fossdal, R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh106 · Cited by 138
Anbanandam, A., Albarado, D. C., Nguyen, C. T. Y., Halder, G. A., Gao, X., & Veeraraghavan, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607171103 · Cited by 136
YAP oncogene overexpression supercharges colon cancer proliferation
Avruch, J., Zhou, D., & Bardeesy, N. M. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19453 · Cited by 136
Vaudin, P., Delanoue, R., Davidson, I., Silber, J., & Zider1, A. (1999) · Development · doi:10.1242/dev.126.21.4807 · Cited by 133
Structures of YAP protein domains reveal promising targets for development of new cancer drugs
Sudol, M., Shields, D. C., & Farooq, A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.05.002 · Cited by 124
Belandia, B., & Parker, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000484200 · Cited by 122
Xiao, J. H., Davidson, I., Ferrandon, D., Rosales, R., Vigneron, M., Macchi, M., Ruffenach, F., & Chambon, P. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02606.x · Cited by 119
Chen, H., Mullett, S. J., & Stewart, A. F. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400154200 · Cited by 116
DNA copy number alterations and expression of relevant genes in triple‐negative breast cancer
Han, W., Jung, E., Cho, J., Lee, J. W., Hwang, K., Yang, S., Kang, J., Bae, J., Jeon, Y. K., Park, I., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20550 · Cited by 110
Hélias‐Rodzewicz, Z., Pérot, G., Chibon, F., Ferreira, C., Lagarde, P., Terrier, P., Coindre, J., & Aurias, A. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20825 · Cited by 110
Milewski, R. C. K., Chi, N. C., Li, J., Brown, C., Lu, M. M., & Epstein, J. A. (2004) · Development · doi:10.1242/dev.00975 · Cited by 109
Coordinating developmental signaling: novel roles for the Hippo pathway
Varelas, X., & Wrana, J. L. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.002 · Cited by 109
MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease
Yoshida, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155788 · Cited by 109
Transcription factor TEAD2 is involved in neural tube closure
Kaneko, K. J., Kohn, M. J., Liu, C., & Depamphilis, M. (2007) · genesis · doi:10.1002/dvg.20330 · Cited by 106
Gaffney, C. J., Oka, T., Mazack, V., Hilman, D., Gat, U., Muramatsu, T., Inazawa, J., Golden, A. M., Carey, D. J., Farooq, A., et al. (2012) · Gene · doi:10.1016/j.gene.2012.08.025 · Cited by 104
Knight, J. F., Shepherd, C. J., Rizzo, S., Brewer, D. S., Jhavar, S. G., Dodson, A. R., Cooper, C. S., Eeles, R. A., Falconer, A., Kovács, G., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604774 · Cited by 97
Webb, C., Upadhyay, A., Giuntini, F., Eggleston, I. M., Furutani‐Seiki, M., Ishima, R., & Bagby, S. (2011) · Biochemistry · doi:10.1021/bi2001888 · Cited by 96
Nowee, M., Snijders, A., Rockx, D., de Wit, R., Kosma, V.-M., Hämäläinen, K. M., Schouten, J., Verheijen, R. H. M., van Diest, P. J., Albertson, D., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2217 · Cited by 93
Kaneko, K. J., Cullinan, E. B., Latham, K. E., & Depamphilis, M. (1997) · Development · doi:10.1242/dev.124.10.1963 · Cited by 92
Skotheim, R. I., Autio, R., Lind, G. E., Kraggerud, S. M., Andrews, P. W., Monni, O. M., Kallioniemi, O., & Lothe, R. A. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/219786 · Cited by 91
Halder, G. A., & Carroll, S. B. (2001) · Development · doi:10.1242/dev.128.17.3295 · Cited by 85
Hucl, T., Brody, J. R., Gallmeier, E., Iacobuzio–Donahue, C. A., Farrance, I. K. G., & Kern, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0474 · Cited by 72
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
Teng, A. C. T., Kuraitis, D., Deeke, S. A., Ahmadi, A. R., Dugan, S. G., Cheng, B. L. M., Crowson, M. G., Burgon, P. G., Suuronen, E. J., Chen, H., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-167049 · Cited by 72
Vestigial-like 3 is an inhibitor of adipocyte differentiation
Halperin, D. S., Pan, C., Lusis, A. J., & Tontonoz, P. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m032755 · Cited by 69
TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters
Maeda, T., Gupta, M. P., & Stewart, A. F. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00556-9 · Cited by 67
VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation
Günther, S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh248 · Cited by 66
Faucheux, C., Naye, F., Tréguer, K., Fédou, S., Thiébaud, P., & Thézé, N. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103080cf · Cited by 50
Vgll2a is required for neural crest cell survival during zebrafish craniofacial development
Johnson, C. W., Hernandez‐Lagunas, L., Feng, W., Melvin, V. S., Williams, T., & Artinger, K. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.06.034 · Cited by 47
Tead proteins activate theFoxa2enhancer in the node in cooperation with a second factor
Sawada, A., Nishizaki, Y., Sato, H., Yada, Y., Nakayama, R., Yamamoto, S., Nishioka, N., Kondoh, H., & Sasaki, H. (2005) · Development · doi:10.1242/dev.02059 · Cited by 46
Cody, N. A. L., Shen, Z., Ripeau, J., Provencher, D. M., Mes‐Masson, A., Chevrette, M., & Tonin, P. N. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20535 · Cited by 39
Mielcarek, M., Piotrowska, I., Schneider, A., Günther, S., & Braun, T. W. (2008) · Gene Expression Patterns · doi:10.1016/j.gep.2008.12.002 · Cited by 38
Malt, A. L., Cagliero, J., Legent, K., Silber, J., Zider, A., & Flagiello, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045498 · Cited by 33
Jin, H., Park, H.-S., Shin, J.-H., Kim, D., Jun, S.-H., Lee, C.-J., & Lee, T. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.117 · Cited by 30
Cited by
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Kim, J., Piao, H.-L., Kim, B.-J., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 771
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Wu, C.-J., Sadanandam, A., Hu, B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.003 · Cited by 716
Regulation of the Hippo Pathway Transcription Factor TEAD
Lin, K. C., Park, H. W., & Guan, K.-L. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.09.003 · Cited by 332
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.10 · Cited by 296
Metadata
- Authors
- Pobbati, A. V., & Hong, W.
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-05
- Volume
- 14
- Issue
- 5
- Pages
- 390-398
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- OpenAlex
- W1967744584
- Cited by
- 253
- References
- 86
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.